Skip to main content

Advertisement

SpringerLink
Log in

Genetic counseling and clinical management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations: perspective of a surgical oncologist

  • Published:
Familial Cancer Aims and scope Submit manuscript

Abstract

Women with a family history of breast cancer who are diagnosed with breast cancer are often counseled to undergo prophylactic mastectomy as part of their treatment for breast cancer. The majority of such individuals make these decisions in haste and without appropriate genetic counseling or testing. Most of them when tested for BRCA or other established mutations find that they are not mutation carriers. In retrospect, this realization leads many to question the wisdom of their prophylactic surgery which is often associated with complications and quality of life problems which they never envisioned. We have designed an algorithm for the management of these patients which minimizes these lifelong problems.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Stolier A, Fuhrman G et al (2004) Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA1 or BRCA2 mutation. Breast J 10:475–480

    Article  PubMed  Google Scholar 

  2. Ganguly A, Leahy K et al (1997) Genetic testing for breast cancer susceptibility: frequency of BRCA1 and BRCA2 mutations. Genet Test 2:85–90

    Google Scholar 

  3. Lakhani SR, van de Vijver MJ et al (2002) The pathology of familial breast cancer: predictive value of immunohistochemical markers, estrogen receptor, progesterone receptor, HER-2 Neu and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol 20:2310–2318

    Article  PubMed  CAS  Google Scholar 

  4. Foulkes WD, Metcalfe K et al (2003) Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma. Cancer 98:1569–1577

    Article  PubMed  Google Scholar 

  5. Brekelmans CTM, Seynaeve C et al (2001) Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. J Clin Oncol 19:924–930

    PubMed  CAS  Google Scholar 

  6. Scheuer L, Kauf N et al (2002) Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol 20:1260–1268

    Article  PubMed  Google Scholar 

  7. Schwartz G, Hortogyi GN (2004) Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of breast, April 26–28, 2003, Philadelphia, Pennsylvania. Cancer 100:2512–2532

    Article  PubMed  Google Scholar 

  8. Wolmark N, Wang J, Mamounas E et al (2001) Preoperative chemotherapy in patients with operable breast cancer: nine-year results from NSABP B-18. J Natl Cancer Inst Monogr 30:96–102

    PubMed  Google Scholar 

  9. Cady B, Chung M et al (2006) Re: genetic counseling and management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations. Breast J 12:282–283

    Article  Google Scholar 

  10. Mammounas EP, Fisher B (2001) Preoperative (neoadjuvant) chemotherapy in patients with breast cancer. Semin Oncol 28:389–399

    Article  Google Scholar 

  11. Tsikitis V, Chung M et al (2004) Scientific basis of neoadjuvant therapy. Semin Breast Dis 7:51–57

    Article  Google Scholar 

  12. Warner E, Trudeau M et al (2003) Sensitivity of BRCA1-related breast cancer to neoadjuvant chemotherapy. Practical implications. Breast J 9:507–508

    Google Scholar 

  13. Pierce LJ, Struderman M et al (2000) Effect of radiotherapy after breast conserving treatment in women with breast cancer and germline BRCA1/2 mutations. J Clin Oncol 18:3360–3369

    PubMed  CAS  Google Scholar 

  14. Hafty B, Harrold E et al (2002) Outcome of conservatively managed early onset breast cancer by BRCA1/2 status. Lancet 359:1471–1477

    Article  Google Scholar 

  15. Komenaka IK, Ditkoff BA et al (2004) The development of interval breast malignancies in patients with BRCA mutations. Cancer 100:2079–2083

    Article  PubMed  CAS  Google Scholar 

  16. Ascherman JA, Hanasono MM et al (2006) Implant reconstruction in breast cancer patients treated with radiation therapy. Plast Reconstr Surg 117:359–365

    Article  PubMed  CAS  Google Scholar 

  17. Narod SA, Offit K (2005) Prevention and management of hereditary breast cancer. J Clin Oncol 23:1656–1663

    Article  PubMed  Google Scholar 

  18. Hartmann LC, Schaid DJ (1999) Effect of bilateral prophylactic mastectomy in women with a familial history of breast cancer. N Engl J Med 340:77–84

    Article  PubMed  CAS  Google Scholar 

  19. Hartmann LC, Sellers TA et al (2001) Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 93:1633–1637

    Article  PubMed  CAS  Google Scholar 

  20. Schwartz M (2005) Contralateral prophylactic mastectomy: efficacy, satisfaction, regret. J Clin Oncol 23:7777–7779

    Article  PubMed  Google Scholar 

  21. Rebbeck TR, Friebel T et al (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers. The PROSE Study Group. J Clin Oncol 221:1055–1062

    Article  Google Scholar 

  22. Meijers-Heijboer H, van Geel B et al (2001) Breast cancer after prophylactic bilateral mastectomy in women with BRCA1 or BRCA2 mutations. N Engl J Med 345:159–164

    Article  PubMed  CAS  Google Scholar 

  23. Walsh T, Casadei S et al (2006) Spectrum of mutations in BRCA1, BRCA2, chek2, and TP53 in families at high risk of breast cancer. JAMA 295:1379–1387

    Article  PubMed  CAS  Google Scholar 

  24. Eisen A, Rebbeck TR et al (2000) Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer. J Clin Oncol 18:1980–1995

    PubMed  CAS  Google Scholar 

  25. Rebbeck TR, Lynch HT et al (2002) Prophylactic oophorectomy in carriers of BRCA1 and BRCA2 mutations. N Engl J Med 346:1616–1621

    Article  PubMed  Google Scholar 

  26. Watson P, Narod SA et al (2003) Carrier risk status changes resulting form mutation testing in hereditary non-polyposis colorectal cancer and hereditary breast ovarian cancer. J Med Genet 40:591–596

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Breast Care, Creighton University Medical Center, 601 N. 30th Street, Suite 2803, Omaha, NE, 68131, USA

    Edibaldo Silva

Authors
  1. Edibaldo Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Edibaldo Silva.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Silva, E. Genetic counseling and clinical management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations: perspective of a surgical oncologist. Familial Cancer 7, 91–95 (2008). https://doi.org/10.1007/s10689-007-9167-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10689-007-9167-3

Keywords

Search

Navigation